D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
Microsoft
MSFT
|
+$524M |
| 4 |
T-Mobile US
TMUS
|
+$411M |
| 5 |
Uber
UBER
|
+$406M |
Top Sells
| 1 |
Visa
V
|
+$567M |
| 2 |
Charles Schwab
SCHW
|
+$531M |
| 3 |
Apple
AAPL
|
+$484M |
| 4 |
Johnson & Johnson
JNJ
|
+$455M |
| 5 |
Accenture
ACN
|
+$401M |
Sector Composition
| 1 | Technology | 25.5% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 12.98% |
| 4 | Financials | 9.15% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Assurant
AIZ
$10.7B
| $3.46M | ﹤0.01% |
27,529
+3,412
| +14% | +$429K |
|
1327
UiPath
PATH
$6.1B
| $3.46M | ﹤0.01% |
208,606
-1,136,287
| -84% | -$18.8M |
|
1328
Latham Group
SWIM
$916M
| $3.45M | ﹤0.01% |
929,090
-74,983
| -7% | -$278K |
|
|
FRBN
1329
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
| $3.44M | ﹤0.01% |
320,688
+6,522
| +2% | +$70K |
|
1330
Wyndham Hotels & Resorts
WH
$6.55B
| $3.42M | ﹤0.01% |
49,894
-167,053
| -77% | -$11.5M |
|
|
JKS
1331
JinkoSolar
JKS
$1.3B
| $3.42M | ﹤0.01% |
76,954
+8,855
| +13% | +$393K |
|
1332
United Parks & Resorts
PRKS
$2.79B
| $3.41M | ﹤0.01% |
60,960
-73,748
| -55% | -$4.13M |
|
1333
Enhabit
EHAB
$399M
| $3.41M | ﹤0.01% |
296,835
-80,316
| -21% | -$924K |
|
1334
Masco
MAS
$15.4B
| $3.41M | ﹤0.01% |
59,484
-46,257
| -44% | -$2.65M |
|
1335
Americold
COLD
$3.93B
| $3.41M | ﹤0.01% |
105,543
-248,966
| -70% | -$8.04M |
|
|
VRTV
1336
DELISTED
VERITIV CORPORATION
VRTV
| $3.41M | ﹤0.01% |
27,137
+3,645
| +16% | +$458K |
|
|
QUOT
1337
DELISTED
Quotient Technology Inc
QUOT
| $3.41M | ﹤0.01% |
886,731
-277,688
| -24% | -$1.07M |
|
1338
Inovio Pharmaceuticals
INO
$126M
| $3.39M | ﹤0.01% |
633,511
+81,941
| +15% | +$439K |
|
1339
Unity
U
$18.4B
| $3.39M | ﹤0.01% |
+78,140
| New | +$3.39M |
|
1340
Red Robin
RRGB
$121M
| $3.39M | ﹤0.01% |
245,291
-11,519
| -4% | -$159K |
|
1341
Ocular Therapeutix
OCUL
$2.23B
| $3.39M | ﹤0.01% |
656,105
-443,665
| -40% | -$2.29M |
|
1342
National Storage Affiliates Trust
NSA
$2.45B
| $3.38M | ﹤0.01% |
97,027
+85,989
| +779% | +$2.99M |
|
|
WBA
1343
DELISTED
Walgreens Boots Alliance
WBA
| $3.38M | ﹤0.01% |
118,563
-92,293
| -44% | -$2.63M |
|
1344
DiamondRock Hospitality
DRH
$1.71B
| $3.38M | ﹤0.01% |
421,387
-156,712
| -27% | -$1.26M |
|
1345
Oshkosh
OSK
$8.77B
| $3.37M | ﹤0.01% |
+38,967
| New | +$3.37M |
|
1346
Kiniksa Pharmaceuticals
KNSA
$2.75B
| $3.36M | ﹤0.01% |
238,600
-1,188
| -0.5% | -$16.7K |
|
1347
Patria Investments
PAX
$2.31B
| $3.35M | ﹤0.01% |
234,411
+221,852
| +1,766% | +$3.17M |
|
1348
Ecolab
ECL
$77.3B
| $3.35M | ﹤0.01% |
17,949
-12,535
| -41% | -$2.34M |
|
|
NPKI
1349
NPK International Inc.
NPKI
$889M
| $3.35M | ﹤0.01% |
640,613
-250,016
| -28% | -$1.31M |
|
|
ROIVW
1350
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
| $3.34M | ﹤0.01% |
1,347,844
| – | – |
|